Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The trial is conducted in Europe and Middle East. The aim of the trial is to compare the use
of Insulin Detemir once or twice daily combined with mealtime Insulin Aspart against that of
NPH Insulin once or twice daily combined with mealtime Insulin Aspart. The trial involves
children and adolescents with Type 1 Diabetes.